April 27, 2026
Boston Cell Standards Enters Final Phase of FDA MDDT Program to Qualify First-in-Industry Platform to Standardize Cancer Diagnostic Assays
Continue Reading
January 20, 2026
Boston Cell Standards Calibrator technology presented at The Pathological Society of Great Britain & Ireland Winter Meeting 2026
Continue Reading
January 6, 2026
International study demonstrates the effectiveness of Boston Cell Standards Calibrators for measuring analytical sensitivity used for breast cancer diagnosis.
Continue Reading
December 1, 2025
Calibration Transforms Accuracy in HER2-Low Breast Cancer Testing
International Study Published in Lancet: eBioMedicine BOSTON – November 19, 2025 — Boston Cell Standards today announced the publication of the CASI-01 study in Lancet: eBioMedicine...
Continue Reading
December 15, 2024
Dutch Immunohistochemistry (IHC) Study Highlights Variability In Breast Cancer Testing and Role of Boston Cell Standards’ (BCS) IHCalibrators® In Enhancing Testing Accuracy Across Labs
Continue Reading